Who invested in Circadian Therapeutics?
Circadian Therapeutics's investors include Oxford Science Enterprises.

Funding summaryUpdated 26 Oct 2026
$2.5Mraised across 1 round since 2016, from 1 source
Circadian Therapeutics's investors include Oxford Science Enterprises.
Circadian Therapeutics has raised $2.5M across 1 round since 2016.
Circadian Therapeutics's most recent round was a Venture of $2.5M in Dec 2016.
Its most recent round, $2.5M in Dec 2016, is also its largest on record.
Circadian Therapeutics's first round on record, in Dec 2016, was backed by Oxford Science Enterprises.
Circadian Therapeutics's latest named round is a Venture, in Dec 2016.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.